| 2 - 2 |
My trip back home to Spain
[Anonymous] |
| 3 - 3 |
Polyiodide chains
Thompson JC |
| 3 - 3 |
Re: molecular machines
Devraj R |
| 3 - 3 |
Vanilla headache
Blanchard EP |
| 5 - 5 |
CRISPR edits sickle cell mutation
Cross R |
| 7 - 7 |
"Chemists are solving mysteries all the time, whether it be in the chemistry lab or in the FBI lab"
McGinnis M |
| 7 - 7 |
U of Hawaii fine lowered by 40%
Kemsley J |
| 7 - 7 |
Antifungal RNA spray protects barley plants
Cross R |
| 8 - 9 |
Ramped-up route to polyrotaxanes
Halford B |
| 8 - 8 |
A new histone tag
Everts S |
| 8 - 8 |
Plant pulls chemical con on freeloader flies
Davenport M |
| 8 - 8 |
Marine microbial dehalogenase adjusts bromine count
Arnaud C |
| 9 - 9 |
Microbes turn coal methoxy groups into methane
Kemsley J |
| 9 - 9 |
Methanol synthesis hinges on catalyst structure
Jacoby M |
| 9 - 9 |
Taking on an organic glow
Halford B |
| 12 - 12 |
Shell eyes chemicals in Iran
Tullo A |
| 12 - 12 |
Total sells Atotech to private equity firm
Reisch M |
| 13 - 13 |
Rotterdam eyed for waste-to-chemicals
Bomgardner M |
| 13 - 13 |
Europe's chemical industry confronts shrinkage
Mccoy M |
| 13 - 13 |
BASF and Avantium move on new polymer
Tullo A |
| 14 - 14 |
BASF sees lower sales and earnings
Bomgardner M |
| 14 - 14 |
Zymergen gets $130 million for microbes
Bomgardner M |
| 14 - 14 |
Avecia builds up drug service business
Mccoy M |
| 14 - 14 |
Merck and PolyOne target 3-D effects
Mccoy M |
| 14 - 14 |
Two firms get new private owners
Reisch M |
| 14 - 14 |
Phenomenex to join Danaher portfolio
Reisch M |
| 14 - 14 |
Indian firm buys Teva UK business
Tremblay JF |
| 14 - 15 |
Japanese firm prevents FDA access
Tremblay JF |
| 15 - 15 |
Four firms get Breakout Labs support
Jarvis L |
| 15 - 15 |
AstraZeneca buys second Amgen site
Jarvis L |
| 15 - 15 |
Helsinn launches venture fund
Thayer A |
| 15 - 15 |
Wacker to research silicones in US
Mccoy M |
| 16 - 16 |
Russia withdraws from nuclear pacts
Dupraz-Dobias P |
| 16 - 16 |
EPA expedites action on five chemicals
Erickson B |
| 17 - 17 |
UK butterfly population on the decline
Erickson B |
| 17 - 17 |
Obama extends program for rare pediatric drugs
Hess G |
| 17 - 17 |
Patent office upholds validity of Shire drug patent
Hess G |
| 17 - 17 |
DOE science office advances chemist
Morrison J |
| 18 - 20 |
A place at the bench
Wang L |
| 21 - 25 |
The art of the chemical bond
Ritter SK |
| 26 - 26 |
A dark discovery
Everts S |
| 26 - 26 |
The Nazi origins of deadly nerve gases
Everts S |
| 27 - 27 |
Taboo development
Everts S |
| 27 - 27 |
A not-so-Nobel cause
Everts S |
| 27 - 27 |
Weaponization and stockpiling
Everts S |
| 28 - 28 |
Self-destruction
Everts S |
| 28 - 28 |
Hitler's veto
Everts S |
| 28 - 28 |
Operation Paperclip
Everts S |
| 29 - 30 |
In China for a Western degree
Tremblay JF |
| 33 - 37 |
The cost of plastic packaging
Tullo AH |
| 38 - 38 |
Building strategic industry-university partnerships
Cesa MC |
| 39 - 41 |
Members for life
Taylor AA |
| 48 - 48 |
Minimal invasion, maximum intensity
Taylor A |
| 48 - 48 |
Artists of the corn
Taylor A |
